Join MSHO members, Daiichi Sankyo US and AstraZeneca in Troy on September 19 to "Learn About the Clinical Data for Enhertu in Metastatic Breast Cancer". For additional information or to register, visit https://lnkd.in/gsxVijCs. #MSHO24
The Michigan Society of Hematology and Oncology’s Post
More Relevant Posts
-
In a VuMedi interview, SCRI expert, Dr. Erika Hamilton shares "The Future of Oral SERDs in Breast Cancer". Watch the full interview today. https://lnkd.in/etFQ6J8C #SABCS23 #BreastCancer #OncologyExpert #ClinicalTrials #advancingscience #transformingcare #cancercare
-
Final Quiz in the Breast Cancer Series! | Applying the Latest Evidence in Breast Cancer: Treatment and Management of Advanced/Metastatic TNBC | 0.25-hour CME/CE | Clinical Case Challenge #4 of 4 | #MedEd #cme #breastcance https://bit.ly/3Qv02kd
-
-
About 7-Methoxyflavone 7-Methoxyflavone impedes the development of breast cancer and could be used as a chemoprevention agent. It may also boost testosterone levels. Know more about #7Methoxyflavone click the link below 👇 https://lnkd.in/gczu8ud6
-
WATCH: Following ASCO GU 2024, a panel of GU medical oncologists discuss recent updates in bladder cancer and provide comprehensive insights on the evolving treatment landscape. #GU24 #oncology https://lnkd.in/eHmfnAwi
Recent Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer
onclive.com
-
It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://lnkd.in/gRc_wcPh Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment
Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way?
event.on24.com
-
Always great to talk to Jeff about the vision and journey of CancerLinQ®, founded by American Society of Clinical Oncology (ASCO) and now an initiative of ConcertAI - Robert Miller https://lnkd.in/dDfy7nP3 #oncodaily #oncology #cancer #technology #data #AI #precisiononcology #RWD #CancerResearch #oncologydata
Robert Miller: Always great to talk to Jeff about the vision and journey of CancerLinQ, founded by ASCO and now an initiative of ConcertAI - OncoDaily
oncodaily.com
-
🌟 New Breast Cancer Screening Guidelines! 🌟 Stay informed about the latest changes in breast cancer screening recommendations. Discover why these updates are crucial for early detection and better outcomes. Empower yourself and your loved ones with this essential knowledge. 💖 Read more here: https://ow.ly/Pmyw50RQ3QU #BreastCancerAwareness #HealthUpdate #EarlyDetection #WomensHealth
-
-
Final Quiz in the Breast Cancer Series! | Applying the Latest Evidence in Breast Cancer: Treatment and Management of Advanced/Metastatic TNBC | 0.25-hour CME/CE | Clinical Case Challenge #4 of 4 | #MedEd #cme #breastcance https://bit.ly/3Qv02kd
-
-
Yardena Samuels discusses how ongoing research is revisiting the classic neoantigen approach - ESMO - European Society for Medical Oncology https://lnkd.in/g8YDjY8Q #oncodaily #oncology #cancer #research #neoantigens #cancerimmunotherapy #immunotherapy
Yardena Samuels discusses how ongoing research is revisiting the classic neoantigen approach - The European Society for Medical Oncology (ESMO) - OncoDaily
oncodaily.com
-
Bria-IMT™ combination regimen was associated with longer than expected progression free survival in a clinical study of 54 MBC patients. Visit BriaCell's clinical study page to learn more about our pivotal Phase 3 study in metastatic breast cancer: https://lnkd.in/e79ajb2X #breastcancer #metastaticbreastcancer #MBC #clinicaltrial #newcancertreatments #innovativecancertreatments #cancertreatments #innovativecancertherapies #clinicalstudy
-
